Valley Fever: Timely Diagnosis, Early Assessment, and Proper Management

Description

This activity is intended to help healthcare providers diagnose coccidioidomycosis and manage uncomplicated illness. Please click here for instructions on how to receive Continuing Education.

Objectives

At the conclusion of the session, the participant will be able to:

  1. Identify three risk factors for Valley fever (coccidioidomycosis)
  2. Recognize three signs and symptoms of coccidioidomycosis
  3. Identify two strategies for diagnosis, management, and treatment of uncomplicated coccidioidomycosis

Moderator

Dr. Tom Chiller, MD, MPHTH
Branch Chief, Mycotic Diseases Branch
Centers for Disease Control and Prevention

Presenters

Dr. John Galgiani, MD
Professor and Director, Valley Fever Center for Excellence
University of Arizona College of Medicine

Dr. George Thompson, MD
Associate Professor of Medicine, Department of Medical Microbiology & Immunology
University of California Davis

Accreditation statements

Continuing Medical Education for Physicians (CME): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention, the Arizona Board of Regents on behalf of The University of Arizona Valley Fever Center for Excellence, and University of California Davis Coccidioidomycosis Serology Laboratory. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Centers for Disease Control and Prevention designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™.

Continuing Nursing Education for Nurses (CNE): The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 0.4 contact hours.

To receive continuing education (CE)

  1. View the course Valley Fever: Timely Diagnosis, Early Assessment, and Proper Management online.
  2. Once you completed the course, go to CDC Training and Continuing Education Online at cdc.gov/tceonline.
    1. If you have not registered as a participant, click on new participant to create a user ID and password; otherwise click on participant login and login.
    2. If you have registered in this system before, please use the same login name and password. This will ensure an accurate transcript.
  3. Once you have logged in/registered, Click on “search” and keyword search for course WD2786.
  4. Click on the course. The course information page will come up. Scroll down to register here. Click on the type of CE that you would like to receive and then submit. Three demographic questions will come up. Complete the questions and then submit.
  5. From “Participant services,” click on “evaluations and tests”.
  6. Answer the questions presented on post-test (all answers are in the course material).
    1. To receive continuing education, you must answer all of the questions and pass the post-test with a score of at least 70%. You can attempt the post-test multiple times.
    2. Some questions have more than one answer. Questions with more than one answer will instruct you to “indicate all that are correct.”
  7. Complete the course evaluation.
  8. You will be able to immediately print your continuing education certificate from your personal transcript.
    1. A record of your completion will be located in the transcript and certificate section of your record.
  9. If you have any questions or problems contact CDC Training and Continuing Education Online at: 1-800-41TRAIN or 404-639-1292 or ce@cdc.gov.

Disclosure

In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, our content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Thompson and he wishes to disclose he provides consulting to Astellas, and receives research support from Astellas, Cidara, Merck, Mayne, Wako, and Scynexis. Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the following exceptions; Dr. Galgiani’s, Dr. Chiller’s, and Dr. Thompson’s discussion of azole antifungal treatment of coccidioidomycosis is only off label. However, all discussion does follow current Infectious Disease Society of America (IDSA) practice guidelines.

The Centers for Disease Control and Prevention, the Arizona Board of Regents on behalf of The University of Arizona Valley Fever Center for Excellence, and University of California Davis Coccidioidomycosis Serology Laboratory are jointly providing the CNE for this activity.

CDC did not accept commercial support for this activity.

For questions about content, please contact

Mycotic Diseases Branch
valleyfever@cdc.gov

Additional information

Fees: No fees are charged for CDC’s CE activities.
Origination date: May 22, 2017
Expiration date: May 22, 2019
Hardware/software: Computer hardware; internet connection; browser
Materials: None
Target audience: Physicians, Registered Nurses
Prerequisites: None
Format: Web on demand

The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention.